PharmAust Limited (PAA.AX)
AUD 0.23
(6.98%)
AUD 0.23
(6.98%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | 2.82 Million | 3.38 Million | 2.14 Million | 3.19 Million | 4.34 Million |
| Cost of Revenue | 1641.00 | 3.75 Million | 3.6 Million | 2.91 Million | 3.61 Million | 333.63 Thousand |
| Gross Profit | -1641.00 | -929.53 Thousand | -223.51 Thousand | -771.53 Thousand | -424.02 Thousand | 4.01 Million |
| Operating Expenses | 6.65 Million | 2.69 Million | 2.52 Million | 2.01 Million | 1.74 Million | 5.53 Million |
| Selling, General and Administrative Expenses | 2.81 Million | 1.66 Million | 1.76 Million | 1.46 Million | 1.14 Million | 4.32 Million |
| Research and Development Expenses | 3.84 Million | 1.03 Million | 758.65 Thousand | 554.14 Thousand | 605.35 Thousand | 1.03 Million |
| Other Expenses | - | 995.36 Thousand | 1.12 Million | 1.51 Million | 924.22 Thousand | 676.29 Thousand |
| Cost and Expenses | 6.65 Million | 6.44 Million | 6.13 Million | 4.92 Million | 5.36 Million | 5.86 Million |
| Operating Income | -6.65 Million | -3.62 Million | -2.74 Million | -2.78 Million | -2.17 Million | -1.52 Million |
| Interest Expense | - | 81.86 Thousand | 88.51 Thousand | 78.98 Thousand | 118.49 Thousand | 47.82 Thousand |
| Income Tax Expense | -553.43 Thousand | 1.00 | 3.00 | -3.00 | 3.00 | 570.00 |
| Earnings before Tax | -9.45 Million | -6.21 Million | -1.7 Million | -1.33 Million | -1.36 Million | -1.55 Million |
| Net Income | -9.03 Million | -6.21 Million | -1.7 Million | -1.33 Million | -1.36 Million | -1.55 Million |
| Earnings Per Share Basic | -0.02 | -0.02 | -0.01 | -0.00 | -0.00 | -0.01 |
| Earnings Per Share Diluted | -0.02 | -0.02 | -0.01 | -0.00 | -0.00 | -0.01 |
| Weighted Average Shares Outstanding | 370.81 Million | 321 Million | 316.88 Million | 315.74 Million | 296.03 Million | 219.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 370.81 Million | 321 Million | 316.88 Million | 315.74 Million | 296.03 Million | 219.32 Million |
| Gross Margin | - | -0.33 | -0.07 | -0.36 | -0.13 | 0.92 |
| EBIT Margin | - | -1.17 | -0.72 | -1.16 | -0.59 | -0.31 |
| Profit Margin | - | -2.20 | -0.51 | -0.62 | -0.43 | -0.36 |
| EBITDA | -9.45 Million | -3.29 Million | -1.3 Million | -960.05 Thousand | -968.85 Thousand | -1.33 Million |
| Earnings Before Tax Margin | - | -1.28 | -0.81 | -1.30 | -0.68 | -0.35 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 857.34 Thousand | 2.82 Million | 908.81 Thousand | 1.91 Million |
| Cost of Revenue | 1641.00 | 1641.00 | - | 3.75 Million | 2.04 Million | 1.7 Million |
| Gross Profit | -1641.00 | -1641.00 | 857.34 Thousand | -929.53 Thousand | -1.13 Million | 208.18 Thousand |
| Operating Expenses | 6.65 Million | 4.19 Million | 2.46 Million | 2.69 Million | 1.51 Million | 1.18 Million |
| Selling, General and Administrative Expenses | - | 1.66 Million | 1.14 Million | - | 908.16 Thousand | 753.19 Thousand |
| Research and Development Expenses | - | 2.52 Million | 1.32 Million | - | 602.14 Thousand | 429.58 Thousand |
| Other Expenses | - | - | - | 995.36 Thousand | - | - |
| Cost and Expenses | 6.65 Million | 4.19 Million | 2.46 Million | 6.44 Million | 3.55 Million | 2.88 Million |
| Operating Income | -6.65 Million | -4.19 Million | -2.46 Million | -3.62 Million | -2.64 Million | -974.59 Thousand |
| Interest Expense | - | - | - | 81.86 Thousand | 39.84 Thousand | 42.01 Thousand |
| Income Tax Expense | -553.43 Thousand | -1.00 | -553.43 Thousand | 1.00 | 3.00 | -654.1 Thousand |
| Earnings before Tax | -9.45 Million | -7.29 Million | -2.15 Million | -6.21 Million | -6.19 Million | -675.29 Thousand |
| Net Income | -9.03 Million | -7.29 Million | -389.24 Thousand | -6.21 Million | -6.19 Million | -21.18 Thousand |
| Earnings Per Share Basic | - | -0.02 | -0.00 | - | -0.02 | -0.00 |
| Earnings Per Share Diluted | - | -0.02 | -0.00 | - | -0.02 | -0.00 |
| Weighted Average Shares Outstanding | 370.81 Million | 445.02 Million | 353.85 Million | 321 Million | 321.02 Million | 316.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 370.81 Million | 445.02 Million | 353.85 Million | 321 Million | 321.02 Million | 316.91 Million |
| Gross Margin | - | - | 1.00 | -0.33 | -1.25 | 0.11 |
| EBIT Margin | - | - | -1.77 | - | -2.73 | -0.42 |
| Profit Margin | - | - | -0.45 | -2.20 | -6.81 | -0.01 |
| EBITDA | - | -4.19 Million | -1.52 Million | - | -2.48 Million | -811.1 Thousand |
| Earnings Before Tax Margin | - | - | -2.87 | -1.28 | -2.91 | -0.51 |
INCREDIBLE
VMART
CHLLTD
DV8
GUJCMDS
600774